Nanoparticle delivery in infant lungs

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5092-7. doi: 10.1073/pnas.1119339109. Epub 2012 Mar 12.

Abstract

The lung surface is an ideal pathway to the bloodstream for nanoparticle-based drug delivery. Thus far, research has focused on the lungs of adults, and little is known about nanoparticle behavior in the immature lungs of infants. Here, using nonlinear dynamical systems analysis and in vivo experimentation in developing animals, we show that nanoparticle deposition in postnatally developing lungs peaks at the end of bulk alveolation. This finding suggests a unique paradigm, consistent with the emerging theory that as alveoli form through secondary septation, alveolar flow becomes chaotic and chaotic mixing kicks in, significantly enhancing particle deposition. This finding has significant implications for the application of nanoparticle-based inhalation therapeutics in young children with immature lungs from birth to 2 y of age.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Inhalation
  • Animals
  • Animals, Newborn
  • Body Weight / physiology
  • Computer Simulation
  • Drug Delivery Systems*
  • Humans
  • Infant
  • Lung / anatomy & histology
  • Lung / growth & development
  • Lung / metabolism*
  • Nanoparticles / administration & dosage*
  • Particle Size
  • Rats
  • Rats, Wistar
  • Respiration
  • Tidal Volume / physiology